Vivos Therapeutics stock price target lowered to $2.50 by H.C. Wainwright
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- Canada’s annual CPI rises to 2.4% as Iran war spikes gasoline costs
- Empery Digital repurchases 26.2M shares under $200M program
- Abrams Capital raises stake in SECURE Waste to 10%
- AVAX One signs letter of intent for 10 MW AI data center in Alberta
- Worksport launches Nexus tonneau cover for light trucks
- Bristow Group COO of government services to retire end of year
News from Other Countries
🇬🇧 United Kingdom
- Should Gabriel have been sent off for Haaland clash?
- Oil prices rise and markets fall after US seizure of ship hits Iran peace deal hopes
- Quarter of a million people could lose job by middle of 2027 as UK ‘flirts with recession’, analysis says